sFlt-1 (Soluble fms-like tyrosine kinase-1) Test - Serum

The sFlt-1 test measures the levels of soluble fms-like tyrosine kinase-1 in a pregnant woman's blood.

• To diagnose the marker for pre-eclampsia during pregnancy, especially in high-risk individuals with underlying conditions such as diabetes, hypertension or lupus
• To start early treatment and improve the chances of a healthy pregnancy outcome
• It can be used to monitor women who are already at risk of preeclampsia.
• It can help diagnose preeclampsia early, which can help prevent complications.

The sFlt-1 test is typically recommended for pregnant women who are at high risk of developing pre-eclampsia, have a history of pre-eclampsia, or have any underlying medical condition such as hypertension, diabetes, or lupus that increases their risk of developing the condition.

Higher than normal levels may indicate an increased risk for pre-eclampsia, which can lead to complications such as seizures, premature birth, and placental abruption.

The sFlt-1 test is a simple blood test that usually requires drawing a small amount of blood from the arm. The sample is tested at a laboratory or a clinic.

Inform your doctor about all medications you are currently taking, including vitamins and supplements as they may affect your test results. Also, consult if there are any specific requirements.

• Blood pressure monitoring
• Urine dipstick test
• Liver and kidney function tests
• Complete blood count

These tests help to evaluate the overall health of the mother and her unborn child and monitor for any signs of complications that may arise.

Pre-eclampsia screening test or pre-eclampsia risk assessment test

Pre-eclampsia is a pregnancy complication characterised by high blood pressure, protein in urine, and sometimes damage to other organs such as the liver or kidneys. It can be life-threatening for both mother and baby, with an increased risk of premature birth, low birth weight, respiratory distress syndrome, and other complications.